Lumena Pharmaceuticals Withdrawn, Nasdaq: LIVR

Clinical-stage biotech developing candidates for rare liver diseases including NASH.

Industry: Other

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Other

Clinical-stage biotech developing candidates for rare liver diseases including NASH.
more less
IPO News for Lumena Pharmaceuticals
more
IPO Data
IPO File Date 04/02/2014
Offer Price
Price Range $0.00 - $0.00
Offer Shares (mm) n/a
Deal Size ($mm) $75
IPO Data
IPO Date
Offer Price
Price Range $0.00 - $0.00
Offer Shares (mm) n/a
Deal Size ($mm) $75
Underwriters
more
Company Data
Headquarters San Diego, CA
Founded 2011
Employees 17
Website www.lumenapharma.com